Dr. Miguel Angel García Pérez is Professor of Genetics at the University of Valencia (UV). He received his doctorate in Biological Sciences from the Cytological Research Institute of the Valencian Foundation for Biomedical Studies. After a brief postdoctoral stay at the Institut de Genetique et de Biologie Moleculaire et Cellulaire from Strasbourg, trained as a Resident Internal Biologist in immunology at Hospital 12 de Octubre in Madrid. In 2002 he obtained a position as a Researcher of the National Health System at the Clinical Hospital of Valencia and later at its Foundation, achieving stabilization in 2008. Since 2011 he has been a researcher attached to INCLIVA.
His main area of interest and research is the genetics of postmenopausal osteoporosis and the functional characterization of the detected genetic variants. He is also very interested in the identification of genetic and epigenetic biomarkers of prevalent bone phenotypes such as osteoporosis, fragility fracture, and severe osteoarthritis. He has worked for a long time with a mouse model of accelerated bone loss such as ovariectomized mice. In this model, he has studied the interrelationship between the immune and bone systems and has served as a source of candidate genes for their translational study in women. More recently, a new line of research began consisting of the genetic study of patients with chromosome 15 duplication inversion syndrome (Idic-15).
He is the author of about 100 articles in different magazines, most of them international, and 14 book chapters. He has participated in about 20 research projects, of which 8 are R+D+I projects (4 as principal investigator) and 2 international projects. He has participated as an expert evaluator in some 15 international journals and as an evaluator of research projects and contracts for the Agencies ANEP, AEI, ACSUCYL, United States -Israel Binational Science Foundation, National Science Center (Poland), Ministry of Health of the Junta de Andalucía, Ministry of Science and Innovation, and Ministry of Economy and Competitiveness.